Current Report Filing (8-k)
July 26 2022 - 04:16PM
Edgar (US Regulatory)
0000051143
false
Capital stock, par value $.20 per share
IBM
CHX
0000051143
2022-07-20
2022-07-20
0000051143
us-gaap:CommonStockMember
exch:XCHI
2022-07-20
2022-07-20
0000051143
us-gaap:CommonStockMember
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes2.625PercentDue2022Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes1.25PercentDue2023Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes0.375PercentDue2023Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes1.125PercentDue2024Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes2.875PercentDue2025Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes0.950PercentDue2025Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes0.875PercentDue2025Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes0.300PercentDue2026Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes1.250PercentDue2027Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes0.300PercentDue2028Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes1.750PercentDue2028Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes1.500PercentDue2029Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes0.875PercentDue2030Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes1.250PercentDue2034Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Notes1.750PercentDue2031Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
exch:XNYS
ibm:Notes0.650PercentDue2032Member
2022-07-20
2022-07-20
0000051143
exch:XNYS
ibm:Notes1.200PercentDie2040Member
2022-07-20
2022-07-20
0000051143
ibm:Debentures7.00PercentDue2025Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Debentures6.22PercentDue2027Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Debentures6.50PercentDue2028Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Debentures7.00PercentDue2045Member
exch:XNYS
2022-07-20
2022-07-20
0000051143
ibm:Debentures7.125PercentDue2096Member
exch:XNYS
2022-07-20
2022-07-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
Title of each class |
Capital stock, par value $.20 per share |
Trading
symbol |
IBM |
|
Common Stock |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report
: July 20, 2022
(Date of earliest
event reported)
INTERNATIONAL
BUSINESS MACHINES CORPORATION
(Exact name of registrant
as specified in its charter)
New York |
|
1-2360 |
|
13-0871985 |
(State of Incorporation) |
|
(Commission File Number) |
|
(IRS employer Identification No.) |
One New Orchard Road
|
|
|
Armonk,
New York |
|
10504 |
(Address of principal executive offices) |
|
(Zip Code) |
914-499-1900
(Registrant’s telephone number)
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
symbol(s) |
|
Name
of each exchange on which registered |
Capital stock, par value $.20 per share |
|
IBM |
|
New York Stock Exchange |
|
|
|
|
NYSE Chicago |
2.625% Notes due 2022 |
|
IBM 22A |
|
New York Stock Exchange |
1.250% Notes due 2023 |
|
IBM 23A |
|
New York Stock Exchange |
0.375% Notes due 2023 |
|
IBM 23B |
|
New York Stock Exchange |
1.125% Notes due 2024 |
|
IBM 24A |
|
New York Stock Exchange |
2.875% Notes due 2025 |
|
IBM 25A |
|
New York Stock Exchange |
0.950% Notes due 2025 |
|
IBM 25B |
|
New York Stock Exchange |
0.875% Notes due 2025 |
|
IBM 25C |
|
New York Stock Exchange |
0.300% Notes due 2026 |
|
IBM 26B |
|
New York Stock Exchange |
1.250% Notes due 2027 |
|
IBM 27B |
|
New York Stock Exchange |
0.300% Notes due 2028 |
|
IBM 28B |
|
New York Stock Exchange |
1.750% Notes due 2028 |
|
IBM 28A |
|
New York Stock Exchange |
1.500% Notes due 2029 |
|
IBM 29 |
|
New York Stock Exchange |
0.875% Notes due 2030 |
|
IBM 30 |
|
New York Stock Exchange |
1.750% Notes due 2031 |
|
IBM 31 |
|
New York Stock Exchange |
0.650% Notes due 2032 |
|
IBM 32A |
|
New York Stock Exchange |
1.250% Notes due 2034 |
|
IBM 34 |
|
New York Stock Exchange |
1.200% Notes due 2040 |
|
IBM 40 |
|
New York Stock Exchange |
7.00% Debentures due 2025 |
|
IBM 25 |
|
New York Stock Exchange |
6.22% Debentures due 2027 |
|
IBM 27 |
|
New York Stock Exchange |
6.50% Debentures due 2028 |
|
IBM 28 |
|
New York Stock Exchange |
7.00% Debentures due 2045 |
|
IBM 45 |
|
New York Stock Exchange |
7.125% Debentures due 2096 |
|
IBM 96 |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Financial Statements and Exhibits.
This Current Report on Form 8-K is being filed to incorporate by reference
into Registration Statement No. 333-262911 on Form S-3, effective February 22, 2022, the documents included as Exhibits 1.1, 4.1, 4.2,
4.3, 4.4, 5.1 and 23.1 relating to $3,250,000,000 aggregate principal amount of debt securities of the Registrant (the “Notes”).
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. |
|
Description of Exhibit |
1.1 |
|
Underwriting Agreement dated July 20, 2022 among International Business Machines Corporation and BNP Paribas Securities Corp., J.P. Morgan Securities LLC, RBC Capital Markets, LLC, Santander Investment Securities Inc. and Wells Fargo Securities, LLC, as Underwriters |
4.1 |
|
Form of 4.000% Note due 2025 |
4.2 |
|
Form of 4.150% Note due 2027 |
4.3 |
|
Form of 4.400% Note due 2032 |
4.4 |
|
Form of 4.900% Note due 2052 |
5.1 |
|
Opinion of Frank Sedlarcik, Vice President, Assistant General Counsel and Secretary regarding the Notes |
23.1 |
|
Consent of Frank Sedlarcik, Vice President, Assistant General Counsel and Secretary (included in Exhibit 5.1) |
104 |
|
Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
IBM’s web site (www.ibm.com) contains a significant amount of
information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit
its various web sites from time to time, as information is updated and new information is posted.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Date: July 26, 2022 |
|
|
|
|
|
By: |
/s/ Simon J. Beaumont |
|
|
Simon J. Beaumont |
|
|
Vice President and Treasurer |
International Business M... (NYSE:IBM)
Historical Stock Chart
From Feb 2024 to Mar 2024
International Business M... (NYSE:IBM)
Historical Stock Chart
From Mar 2023 to Mar 2024